Implementation strategies to scale up self-administered depot medroxyprogesterone acetate subcutaneous injectable contraception: a scoping review

BACKGROUND: Self-administered depot medroxyprogesterone acetate subcutaneous injectable contraception (DMPA-SC) is registered in many countries. It shows great potential for improving contraceptive access, continuation, and autonomy. However, there are challenges in rolling out this new efficacious...

Descripción completa

Detalles Bibliográficos
Autores principales: Aderoba, Adeniyi Kolade, Steyn, Petrus Schoken, Kiarie, James Njogu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318699/
https://www.ncbi.nlm.nih.gov/pubmed/37403147
http://dx.doi.org/10.1186/s13643-023-02216-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318699/
https://www.ncbi.nlm.nih.gov/pubmed/37403147
http://dx.doi.org/10.1186/s13643-023-02216-2

Ejemplares similares